
Cefzit-CV 625 Tablet
Marketer
Zither Pharmaceutical Pvt Ltd
Salt Composition
Cefuroxime (500mg) + Clavulanic Acid (125mg)
Overview Cefzit-CV 625 Tablet
Combiflam-CV 625mg tablets combat various bacterial infections by inhibiting microbial growth and propagation. This prescription medication should be taken precisely as directed. Consumption with or without food is acceptable, but consistent timing maximizes effectiveness. Exceeding the prescribed dosage may be detrimental. Missed doses should be taken immediately upon recollection. Treatment completion is crucial; premature cessation can compromise its effectiveness. Common side effects include nausea, vomiting, diarrhea, and dyspepsia; worsening side effects require immediate medical attention. Allergic reactions (rash, pruritus, edema, dyspnea) necessitate urgent medical consultation. Inform your physician of all current medications before commencing treatment. Pregnant or lactating individuals require prior medical consultation. Alcohol consumption should be avoided due to potential additive drowsiness. While it typically doesn't affect driving ability, avoid driving if drowsiness or dizziness occur. Adequate rest, a nutritious diet, and sufficient hydration are essential for optimal recovery. Your physician may order lab tests to monitor the medicine's effects.
Uses of Cefzit-CV 625 Tablet
Combating Bacterial Infections
Major Benefits of Cefzit-CV 625 Tablet:
Consume this medication precisely as directed by your physician, adhering to both the prescribed dosage and duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Cefzit-CV 625 Tablets can be administered with or without food; however, consistent timing is recommended.
Common Side effects of Cefzit-CV 625 Tablet:
- Nausea
- Vomiting
- Diarrhea
- Increased liver enzymes
- Allergic reaction
How to use Cefzit-CV 625 Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Cefzit-CV 625 Tablet whole; avoid chewing, crushing, or fracturing it. This medication can be administered with or without food, however, consistent timing is recommended.
How Cefzit-CV 625 Tablet works:
Cefuroxime and Clavulanic Acid, combined as Cefzit-CV 625 Tablet, offer targeted antibacterial action. Cefuroxime, an antibiotic, disrupts bacterial cell wall synthesis, hindering bacterial survival. Clavulanic Acid, a beta-lactamase inhibitor, counteracts bacterial enzymes that would otherwise neutralize Cefuroxime's effects. This synergistic combination broadens Cefuroxime's effectiveness by overcoming bacterial resistance mechanisms.
SAFETY ADVICE
AlcoholSAFE
Alcohol consumption alongside Cefzit-CV 625 Tablets does not produce adverse reactions.
PregnancySAFE IF PRESCRIBED
The medication Cefzit-CV 625 Tablet is typically deemed safe for use during gestation. Preclinical trials in animals have revealed minimal or absent negative impacts on fetal development; nevertheless, data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
Cefzit-CV 625 Tablets are considered safe for use while breastfeeding. Research in humans indicates minimal drug transfer to breast milk, posing no known risk to the infant.
DrivingNOT RELEVANT
Cefzit-CV 625 Tablet is exclusively for inpatient administration.
KidneyCONSULT YOUR DOCTOR
Data regarding Cefzit-CV 625 Tablet use in patients with renal impairment is scarce. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Data regarding Cefzit-CV 625 Tablet use in individuals with hepatic impairment is scarce. Physician consultation is recommended.
What if you forget to take Cefzit-CV 625 Tablet :
Should you forget a Cefzit-CV 625 Tablet dose, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual regimen. Avoid taking a double dose.
Facts to Know About Cefzit-CV 625 Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
